22MB110N DC Vaccine: Enriching Monocyte Derived Dendritic Cells to Create DC Vaccine based Immunotherapy Using L-Fucose
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE
The Innovation Office
InnovationMarketing@Moffitt.org
(813) 745-6828